insights_auto
Why is VSTM down 3.08%?
Dive Deeperchevron_right
VSTM:NASDAQ
Verastem Inc
$8.18
arrow_downward
-3.08%(-0.26) 1D
$7.99
arrow_downward
-2.32% (-0.19)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$8.40
High
$8.40
Low
$7.98
Mkt. cap
1.03B
Avg. vol.
4.89M
Volume
1.72M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$1.85
Beta
0.45
Shares outstanding
126.02M
No. of employees
102
Open
$8.40
High
$8.40
Low
$7.98
Mkt. cap
1.03B
Avg. vol.
4.89M
Volume
1.72M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$1.85
Beta
0.45
Shares outstanding
126.02M
No. of employees
102
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Verastem Stock In Focus After Earnings Update And New Financing Plans
Investing.com
·
3 days ago
Verastem at Wolfe healthcare conference: G12D push gains speed
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteverastem.com